Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

The Journal of Infectious Diseases
Kieren A MarrThomas J Walsh

Abstract

Invasive aspergillosis (IA) is a frequent complication of blood or marrow transplantation. Previous studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic tool for IA, but its sensitivity is variable. We examined the performance of the GM EIA in 986 serum samples from 67 patients. Results demonstrated that decreasing the index cutoff for positivity to 0.5 increased its sensitivity, with minimal loss of specificity. The low cutoff increased the duration of test positivity before diagnosis by clinical means. Sensitivity was highest in patients who did not receive preventative mold-active antifungals (87.5%). A rabbit model demonstrated that the level of circulating antigen correlated with the tissue fungus burden. A quantifiable response to antifungal therapy in clinical samples and the rabbit model supports the development of this assay for early diagnosis and therapeutic monitoring. The 0.5 cutoff may allow for better performance as an early diagnostic test.

Associated Clinical Trials

Citations

Mar 15, 2006·Annals of Hematology·Stefan Neuburger, Georg Maschmeyer
May 29, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Markéta MarkováMartin Haluzík
Sep 13, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M MichalletP Vanhems
Nov 15, 2007·Current Infectious Disease Reports·L Joseph Wheat
Oct 28, 2009·Current Infectious Disease Reports·Joshua Wolf, Monica A Slavin
Sep 19, 2006·Bone Marrow Transplantation·C C HofmeisterP J Stiff
May 1, 2009·The New England Journal of Medicine·Brahm H Segal
Aug 23, 2005·Medical Mycology·C CordonnierS Bretagne
Aug 23, 2005·Medical Mycology·J R Perfect
Aug 23, 2005·Medical Mycology·N G AlmyroudisB H Segal
Aug 23, 2005·Medical Mycology·P E Verweij
Aug 23, 2005·Medical Mycology·T F Patterson
Nov 21, 2007·Medical Mycology·Javier CapillaDavid A Stevens
Jul 26, 2008·Medical Mycology·K V Clemons, D A Stevens
Mar 3, 2009·Medical Mycology·Marisa Miceli, Elias Anaissie
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrWendy Leisenring
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensNicholas Kartsonis
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben E de Pauw, Thomas F Patterson
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A Marr, Wendy Leisenring
Sep 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M WeisserU Fluckiger
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensJohan Van Eldere
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben E de Pauw
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher D PfeifferNasia Safdar
Nov 4, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nikolaos G AlmyroudisBrahm H Segal
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Arlo UptonKieren A Marr
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan A MaertensPaul E Verweij
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J Anaissie
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
Feb 12, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laurence SennOscar Marchetti
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marisa H MiceliElias Anaissie
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jul 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brahm H SegalBen E De Pauw
Aug 30, 2008·The Journal of Infectious Diseases·Susanne PerkhoferCornelia Lass-Flörl
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yasmine NivoixRaoul Herbrecht
Sep 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M RuhnkeUNKNOWN Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amar Safdar, Donald Armstrong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Kieren A MarrWendy Leisenring
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Raoul HerbrechtErmanno Candolfi
© 2022 Meta ULC. All rights reserved